Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag

Jan 29, 2025 · Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag. Danaher Corporation (NYSE:DHR) shares are trading lower in the premarket session on Wednesday.. …

CouponFollow Extension

3%
OFF

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag

2 weeks from now

Jan 29, 2025 · Danaher's Q4 adjusted EPS missed estimates, while sales of $6.54B exceeded forecasts, driven by biotech and life sciences growth. The diagnostics segment saw a 3% …

benzinga.com

4%
OFF

Danaher Corp (DHR) Q4 2024 Earnings Call Highlights: Strategic …

2 weeks from now

Jan 31, 2025 · Fourth Quarter Adjusted Diluted Net Earnings Per Share: $2.14, up 2.4% year-over-year. Fourth Quarter Free Cash Flow: $1.5 billion. Biotechnology Segment Core …

yahoo.com

1%
OFF

Earnings Call Transcript: Danaher Q4 2024 Sees Revenue Beat ... - MSN

2 weeks from now

Danaher's Q4 2024 revenue exceeded forecasts by $150 million. EPS was marginally below expectations, at $2.14 versus $2.15. Stock price rose by 1% in pre-market trading.

msn.com

1%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Jan 29, 2025 · DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments. Danaher Q4 Earnings Miss …

zacks.com

$2.14
OFF

Danaher Shares Fall As Q4 Earnings Miss Estimates, Revenue Beats

2 weeks from now

Jan 29, 2025 · Danaher shares fall as Q4 earnings miss estimates, revenue beats ... The life sciences and diagnostics company posted adjusted earnings per share of $2.14, falling short …

investing.com

1%
OFF

Danaher Fourth-Quarter Earnings Miss Estimates; Expects Decline …

2 weeks from now

Jan 29, 2025 · Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital …

marketscreener.com

5%
OFF

Danaher Stock Falls The Most Since 2023. Why Earnings Were Such …

2 weeks from now

Jan 29, 2025 · Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag ... The Biotechnology segment gained 6.5% year over year in the quarter under review, while the Life …

yahoo.com

4%
OFF

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2 weeks from now

Jan 29, 2025 · Danaher Corporation’s DHR fourth-quarter 2024 adjusted earnings of $2.14 per share missed the Zacks Consensus Estimate of $2.17. The bottom line increased 2.4% year …

tradingview.com

8%
OFF

We're Cutting Our Price Target On Danaher As Frustration Mounts …

2 weeks from now

Jan 29, 2025 · Shares tumbled more than 8% after in response to fourth-quarter earnings and 2025 guidance.

cnbc.com

12%
OFF

Danaher Corporation (DHR) Interactive Stock Chart - Yahoo Finance

2 weeks from now

DHR announced quarterly EPS of $2.14, missing expectations by 1.12%. ... Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y ... EPS Miss Expectations Amid Diagnostics …

yahoo.com

$2.14
OFF

Owler Reports - Danaher: Danaher Q4: EPS Miss Expectations …

2 weeks from now

Danaher Corporation (NYSE: DHR ) shares are trading lower in the premarket session on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 …

owler.com

2%
OFF

Danaher Reports Q4 Revenue Growth Amid Diagnostics Decline; …

2 weeks from now

6 days ago · Danaher Corporation's Q4 2024 results reveal a mixed bag: a 2% revenue growth driven by Life Sciences, yet a 3% decline in Diagnostics led to a 7% drop in shares. With a …

folikoinsights.com

$2.14
OFF

Danaher Reports Q4 Earnings Miss Amid Weak Biotech Demand

2 weeks from now

Danaher Corporation reported its fourth-quarter results, revealing a miss on profit expectations with adjusted earnings of $2.14 per share, slightly below the $2.16 forecast by analysts. …

vtnews.ai

5%
OFF

Danaher Full Year 2024 Earnings: EPS Misses Expectations

2 weeks from now

Jan 31, 2025 · Danaher EPS Misses Expectations. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.5%. The primary driver behind last …

sahmcapital.com

1%
OFF

Earnings Call Transcript: Danaher Q4 2024 Sees Revenue Beat, Stock ...

2 weeks from now

Jan 31, 2025 · Following the earnings release, Danaher's stock experienced a 1% increase in pre-market trading, reflecting positive investor sentiment despite the minor EPS miss. Key …

investing.com

$16
OFF

Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?

2 weeks from now

Jan 29, 2025 · Check This Out: Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag Outlook: Teva Pharmaceutical expects full-year 2025 revenue to be in the range of $16.8 …

benzinga.com

FAQs about Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag Coupon?

How did Danaher (DHR) perform in Q4 2024?

Danaher Corporation (NYSE:DHR) reported its fourth-quarter 2024 earnings, revealing a slight miss in earnings per share (EPS) compared to forecasts but surpassing revenue expectations. The company posted an EPS of $2.14, just below the anticipated $2.15, while revenue reached $6.54 billion, exceeding the forecast of $6.39 billion. ...

Does Danaher have diagnostics?

Matt McGrew, Executive Vice President and Chief Financial Officer, Danaher Corporation: Yes, sure. Let me see if I captured all that. As far as Diagnostics goes, I think you're right, Doug. I mean, I think if you sort of think about Diagnostics maybe just outside of China, we are kind of mid to high single digits here for the guide. ...

How did Danaher perform in 2024?

For the full year 2024, Danaher reported revenues of $23.9 billion, flat compared to 2023, while non-GAAP core revenue decreased 1.5%. Operating cash flow was $6.7 billion and non-GAAP free cash flow reached $5.3 billion. 3rd party Ad. ...

What changed in diagnostics in Q4 compared to Q1 2024?

But we really saw 2 meaningful changes in diagnostics in the Q4, and Matt described some of those. 1 was the acceleration of volume based procurement in China, and the second is a slower start to the respiratory season. You bring that together between volume based procurement and respiratory, that's about a 3 50 basis point headwind versus Q1 2024. ...

What will Danaher expect in the first quarter of 2025?

In the first quarter of 2025, Danaher expects a low single-digit decline in core revenue, with an adjusted operating profit margin around 26.5%. CEO Rainer Blair highlighted the company's strong finish to the year, stating, "We finished the year strong with better than anticipated core revenue in all three of our segments." ...

Where can I find information about Danaher Corporation's financial performance?

: and John Bedford, Vice President of Investor Relations, Danaher Corporation: a note containing details of historical and anticipated future financial performance are all available on the Investors section of our website, www.danahurt.com, under the heading Quarterly Earnings. ...